| 000 | 01557 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515133002.0 | ||
| 264 | 0 | _c20081211 | |
| 008 | 200812s 0 0 eng d | ||
| 022 | _a1502-7732 | ||
| 024 | 7 |
_a10.1080/03009740802144143 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHoshina, T | |
| 245 | 0 | 0 |
_aHigh mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease. _h[electronic resource] |
| 260 |
_bScandinavian journal of rheumatology _c |
||
| 300 |
_a445-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntigens, Differentiation, B-Lymphocyte _xmetabolism |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 |
_aHMGB1 Protein _xblood |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class II _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _xmetabolism |
| 650 | 0 | 4 |
_aMacrophage Migration-Inhibitory Factors _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMucocutaneous Lymph Node Syndrome _xblood |
| 650 | 0 | 4 | _aReceptor for Advanced Glycation End Products |
| 650 | 0 | 4 |
_aReceptors, Immunologic _xmetabolism |
| 650 | 0 | 4 |
_aSepsis _xblood |
| 700 | 1 | _aKusuhara, K | |
| 700 | 1 | _aIkeda, K | |
| 700 | 1 | _aMizuno, Y | |
| 700 | 1 | _aSaito, M | |
| 700 | 1 | _aHara, T | |
| 773 | 0 |
_tScandinavian journal of rheumatology _gvol. 37 _gno. 6 _gp. 445-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/03009740802144143 _zAvailable from publisher's website |
| 999 |
_c18192115 _d18192115 |
||